Literature DB >> 19585503

Characteristics of menstruation and pregnancy and the risk of lung cancer in women.

Anita Koushik1, Marie-Elise Parent, Jack Siemiatycki.   

Abstract

Lung tissue, both normal and cancerous, has been found to express estrogen receptors and patterns of expression have differed between men and women, suggesting a possible role for hormone-related factors in lung carcinogenesis in women. Few epidemiological studies have examined hormone-related variables and lung cancer risk and the findings have not been consistent. We investigated the association between characteristics of menstruation and pregnancy in relation to lung cancer risk in a population-based case-control study carried out in Montreal, Canada, including 422 women with lung cancer and 577 controls. For each variable, odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression modeling. Associations were also examined according to level of smoking and by lung cancer histology. All statistical tests were two-sided. Most characteristics of menstruation and pregnancy were not associated with lung cancer risk. However, an increased risk was observed for women who had had a non-natural menopause, which predominantly included women who had had a bilateral oophorectomy, compared with women who had had a natural menopause (OR = 1.92, 95% CI: 1.22-3.01). An inverse association with age at menopause was suggested. These results did not vary by level of smoking and they were similar for adenocarcinomas compared with other histological types. Our results suggest that hormonal factors, related to early menopause and/or ovary removal, may play a role in the risk of lung cancer. Further studies are needed to confirm these findings, and to assess the possible contribution of hormone replacement therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19585503     DOI: 10.1002/ijc.24560

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium.

Authors:  Soumaya Ben Khedher; Monica Neri; Alexandra Papadopoulos; David C Christiani; Nancy Diao; Curtis C Harris; Susan Olivo-Marston; Ann G Schwartz; Michele Cote; Anita Koushik; Jack Siemiatycki; Maria Teresa Landi; Rayjean J Hung; John McLaughlin; Eric J Duell; Angeline S Andrew; Irene Orlow; Bernard J Park; Hermann Brenner; Kai-Uwe Saum; Angela C Pesatori; Isabelle Stücker
Journal:  Int J Cancer       Date:  2017-05-10       Impact factor: 7.396

2.  Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Lauren Schwartz; Margaret R Spitz; Yikyung Park; Albert R Hollenbeck; Gretchen L Gierach
Journal:  Cancer Causes Control       Date:  2012-02-25       Impact factor: 2.506

3.  Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study.

Authors:  Christina S Baik; Gary M Strauss; Frank E Speizer; Diane Feskanich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-25       Impact factor: 4.254

4.  Lung cancer in women: role of estrogens.

Authors:  Subhankar Chakraborty; Apar Kishor Ganti; Alissa Marr; Surinder K Batra
Journal:  Expert Rev Respir Med       Date:  2010-08       Impact factor: 3.772

5.  Bilateral oophorectomy and risk of cancer in African American women.

Authors:  Deborah A Boggs; Julie R Palmer; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2014-02-01       Impact factor: 2.506

6.  Body mass index and risk of lung cancer among never, former, and current smokers.

Authors:  Llewellyn Smith; Louise A Brinton; Margaret R Spitz; Tram Kim Lam; Yikyung Park; Albert R Hollenbeck; Neal D Freedman; Gretchen L Gierach
Journal:  J Natl Cancer Inst       Date:  2012-03-27       Impact factor: 13.506

7.  Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort.

Authors:  Louise A Brinton; Gretchen L Gierach; Abegail Andaya; Yikyung Park; Arthur Schatzkin; Albert R Hollenbeck; Margaret R Spitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

8.  Risk of de novo cancer after premenopausal bilateral oophorectomy.

Authors:  Nan Huo; Carin Y Smith; Liliana Gazzuola Rocca; Walter A Rocca; Michelle M Mielke
Journal:  Am J Obstet Gynecol       Date:  2021-11-10       Impact factor: 8.661

9.  Reproductive factors and risk of lung cancer in female textile workers in Shanghai, China.

Authors:  Lisa G Gallagher; Karin A Rosenblatt; Roberta M Ray; Wenjin Li; Dao L Gao; Katie M Applebaum; Harvey Checkoway; David B Thomas
Journal:  Cancer Causes Control       Date:  2013-04-13       Impact factor: 2.506

10.  Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.

Authors:  Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.